Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colorectal Neoplasms 10Urinary Bladder Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1First-line Treatment 1Colorectal Cancer Metastatic 1Colonic Neoplasms 1Clinical Stage III Gastric Cancer AJCC v8 1

Interventions

Cisplatin 51Gemcitabine 24Radiotherapy, Intensity-Modulated 21Docetaxel 20Fluorouracil 15camrelizumab 12Drug Therapy 11Radiotherapy 10toripalimab 8Chemoradiotherapy 8Capecitabine 8apatinib 7Induction Chemotherapy 7nimotuzumab 6endostar protein 6Endostatins 6sintilimab 5nedaplatin 5Bevacizumab 5fludarabine 4Cyclophosphamide 4spartalizumab 3fludarabine phosphate 3cisplatin-guanosine adduct 3SSRP1 protein, human 3Paclitaxel 3Injections 3Endoscopy 3tislelizumab 2Vitamin B 12 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Nasopharyngeal Carcinoma × trifluridine tipiracil drug combination × Clear all
NCT04627961 2020-11-13

A Trial of LONSURF in Recurrent/Metastatic Nasopharyngeal Carcinoma

National University Hospital, Singapore

Phase 2 Unknown
33 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡